|
Abstract: . . . thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis . Blood 2002; 100:3484-3488. 21. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. New Engl J Med 2003;349:146-153 Clinical Guide: Cancer & Thrombosis . . . . . . thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis . Blood 2002; 100:3484-3488. 21. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. New Engl J Med 2003;349:146-153 Clinical Guide: Cancer & Thrombosis . . . . . . and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis . Blood 2002; 100:3484-3488. 21. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. New Engl J Med 2003;349:146-153 Clinical Guide: Cancer & Thrombosis . . . . . . complications during anticoagulant treatment in patients with cancer and venous thrombosis . Blood 2002; 100:3484-3488. 21. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. New Engl J Med 2003;349:146-153 Clinical Guide: Cancer & Thrombosis . . . --3000,4,375,1922,15867
|